Literature DB >> 11683286

Tinea capitis in Europe: new perspective on an old problem.

R J Hay1, W Robles, G Midgley, M K Moore.   

Abstract

A survey of tinea capitis conducted under the auspices of the European Confederation of Medical Mycology showed that laboratories contributing to a voluntary scheme for reporting have recently been seeing a different pattern of scalp ringworm. The survey was conducted among 92 medical mycology laboratories across 19 European countries by postal questionnaire comparing the years 1987 with 1997. The survey shows an overall increase in the numbers of cases caused by anthropophilic infections, which, in 1997, were the dominant causes of scalp infection; the greatest increase was seen in laboratories covering urban populations and in African Caribbean children living in Europe. While the commonest infection remains Microsporum canis, the largest overall increase has been in Trichophyton tonsurans, which in 1997 was the second commonest cause of infection overall and the commonest in urban populations. The pattern of change is not uniform in Europe and while some cities have reported large increases in T. tonsurans others, e.g. in France, have seen more cases of infection due to T. soudanense and M. audouinii. While these figures do not necessarily reflect changes in the underlying prevalence of infection, the trends are important to recognize as the control measures for anthropophilic tinea capitis differ from those used in zoophilic infections. In particular there is a need for an increased level of surveillance and more advice on control given to primary care physicians, dermatologists and school health authorities.

Entities:  

Mesh:

Year:  2001        PMID: 11683286     DOI: 10.1046/j.1468-3083.2001.00214.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  19 in total

Review 1.  Diagnosis and management of scalp ringworm.

Authors:  L C Fuller; F J Child; G Midgley; E M Higgins
Journal:  BMJ       Date:  2003-03-08

2.  Kerion mimicking bacterial infection in an elderly patient.

Authors:  Sheikh Manzoor Ahmad; Gh Mohiuddin Wani; Bilques Khursheed
Journal:  Indian Dermatol Online J       Date:  2014-10

3.  [Mycological laboratory].

Authors:  B Beifuss; C Borelli; H C Korting
Journal:  Hautarzt       Date:  2006-06       Impact factor: 0.751

4.  Successful identification of clinical dermatophyte and Neoscytalidium species by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Kinda Alshawa; Jean-Luc Beretti; Claire Lacroix; Martine Feuilhade; Brunhilde Dauphin; Gilles Quesne; Noura Hassouni; Xavier Nassif; Marie-Elisabeth Bougnoux
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

Review 5.  Asymptomatic dermatophyte scalp carriage: laboratory diagnosis, epidemiology and management.

Authors:  Macit Ilkit; Hakan Demirhindi
Journal:  Mycopathologia       Date:  2007-11-23       Impact factor: 2.574

Review 6.  [Conventional and molecular diagnosis of cutaneous mycoses].

Authors:  C Borelli; B Beifuss; S Borelli; M Schaller; H C Korting
Journal:  Hautarzt       Date:  2008-12       Impact factor: 0.751

Review 7.  [Tropical dermatology-relevant disorders of the scalp].

Authors:  A Montag
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

Review 8.  Allergy and dermatophytes.

Authors:  Judith A Woodfolk
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

9.  In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis.

Authors:  D M Saunte; F Simmel; N Frimodt-Moller; L B Stolle; E L Svejgaard; M Haedersdal; C Kloft; M C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

10.  Tinea capitis in the paediatric population in Milan, Italy: the emergence of Trichophyton violaceum.

Authors:  Elisabetta Teodolinda Maria Mapelli; A Cerri; C Bombonato; S Menni
Journal:  Mycopathologia       Date:  2013-06-28       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.